Hormonal, Metabolic, and Signaling Interactions in PAH
This study is currently recruiting participants.
Verified February 2017 by Jim Loyd, Vanderbilt University
First Posted: June 21, 2013
Last Update Posted: October 31, 2017
Information provided by (Responsible Party):
Jim Loyd, Vanderbilt University
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is currently recruiting participants.|
|Estimated Study Completion Date:||July 2022|
|Estimated Primary Completion Date:||July 2022 (Final data collection date for primary outcome measure)|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Shenoy V, Kwon KC, Rathinasabapathy A, Lin S, Jin G, Song C, Shil P, Nair A, Qi Y, Li Q, Francis J, Katovich MJ, Daniell H, Raizada MK. Oral delivery of Angiotensin-converting enzyme 2 and Angiotensin-(1-7) bioencapsulated in plant cells attenuates pulmonary hypertension. Hypertension. 2014 Dec;64(6):1248-59. doi: 10.1161/HYPERTENSIONAHA.114.03871. Epub 2014 Sep 15. Erratum in: Hypertension. 2015 Mar;65(3):e8.